This article is more than 5 years old. Information may no longer be current.
Allergan reports increased sales for Q1 2003
Click Here to Manage Email Alerts
IRVINE, Calif. — Allergan Inc. announced net sales of $391.2 million for the first quarter 2003 and declared a first quarter dividend of $0.09 per share.
According to the company, net sales include $21.2 million in nonpharmaceutical product sales consisting primarily of contract manufacturing sales to Advanced Medical Optics Inc. Excluding nonpharmaceutical product sales, net sales increased 14.6% compared with net sales in the first quarter 2002.
The company reported a 76.7% increase to $0.53 in diluted earnings per share. Diluted earnings from continuing operations increased to $0.54 per share.
Worldwide eye care pharmaceutical sales increased 6.4% to $221.0 million or 4.6% at constant currency. Net sales of Alphagan products increased 3.3% to $77.3 million or an increase of 1.5% at constant currency. Net sales of Lumigan increased 80.1% to $38 million or an increase of 75.4% at constant currency. Net sales of Botox and Botox Cosmetic increased 38.9%, totaling $123.1 million or a 36.9% increase at constant currency.
The company estimates second quarter total worldwide sales to be between $415 million and $435 million.